The ECS or endocannabinoid system is a messaging system in your body (a series of chemical transmitters and receptors) that modulate just about every physiological function in your body. An under-functioning ECS can lead to Clinical Endocannabinoid Deficiency Syndrome or CEDS.
Clinical Endocannabinoid Deficiency Syndrome (CEDS) occurs when your endocannabinoid system is under functioning. This can happen for many reasons, such as lifestyle triggers or genetic factors and can present as many indications.
The endocannabinoid system (ECS):
The ECS is a network of chemical signals and cellular receptors that are densely packed throughout our brains and bodies. CB1 and CB2 are two key cannabinoid receptors that control the levels of activity for the points above. Essentially, these receptors regulate many bodily functions by letting different parts of our body talk to one another. If we are hungry or full, hot or cold, happy or sad our ECS adjusts our body accordingly to meet the needs of our external environment.
In order for our body to regulate these functions, it naturally produces endocannabinoids, which are structurally similar to the compounds found in the cannabis plant. The first endocannabinoid was discovered in 1992 by our dear friend Dr Raphael Mechoulam. It was named anandamide after the Sanskrit word for bliss. Since then, we have discovered our body makes several endocannabinoids which all have an important role in the normal function of our body. This is a relatively new area of research and we are still discovering new endocannabinoids and the part they play in our physiology.
Today, we have a wealth of research that is indicating some symptoms are the result of our body’s inability to produce an adequate amount of endocannabinoids.
Director of Clinical R&D at Kensana Health
Dr. Newbold covers a range of topics from what our endocannabinoid system is and what we are able to accomplish by treating it with cannabinoid-based medications today.
Director of Clinical R&D at Kensana Health
Dr Carrie Newbold discusses the process of gathering data in relation to cannabinoid medications and the importance of such information. This video also contains information on eCS clinic’s REST trial.
Otherwise, if you have questions feel free to reach out to our clinic team:
03 9117 9000, Australia-wide
clinic@ecs.health
Mon - Friday: 9:00AM - 5:00PM AEST
Mon - Sat: 9:00AM - 9:00PM AEST
We’re here to support you. Our team are experts on the endocannabinoid system and the treatments used for Clinical Endocannabinoid Deficiency Syndrome.
If you need urgent medical attention, please dial 000 immediately.
Our vision is to create the world’s leading endocannabinoid community through research, education, and evidence-based medical cannabis treatment.
Schedule an appointment at our clinic, for Telehealth, phone or in person consultations. Book online or over the phone for consultations, available Australia-wide.
eCS Clinic is a subsidiary of Kensana Health, a vertically-integrated biotechnology and phytopharmaceutical company.
eCS Clinic acknowledges the Traditional Owners of Country throughout Australia. We pay our respects to Elders past, present, and emerging.
ECS Clinic © 2021-22 All rights reserved. Privacy Policy
Designed and Developed by Hyro